The Pennant Group, Inc. (PNTG)
USD 28.15
(-3.63%)
USD 28.15
(-3.63%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 88.99 Million USD | 7.5% |
| 2022 | 38.88 Million USD | -5.27% |
| 2021 | 41.04 Million USD | 14.1% |
| 2020 | 35.97 Million USD | -7.64% |
| 2019 | 38.94 Million USD | 78.59% |
| 2018 | 21.8 Million USD | 28.22% |
| 2017 | 17 Million USD | 11.14% |
| 2016 | 15.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 11.48 Million USD | -3.75% |
| 2024 Q1 | 11.92 Million USD | 18.7% |
| 2023 Q1 | 9.98 Million USD | 4.54% |
| 2023 FY | 41.79 Million USD | 7.5% |
| 2023 Q2 | 10 Million USD | 0.2% |
| 2023 Q3 | 10.74 Million USD | 7.35% |
| 2023 Q4 | 10.04 Million USD | -6.44% |
| 2022 Q4 | 9.55 Million USD | 33.96% |
| 2022 FY | 38.88 Million USD | -5.27% |
| 2022 Q3 | 7.13 Million USD | -35.3% |
| 2022 Q2 | 11.02 Million USD | -1.43% |
| 2022 Q1 | 11.18 Million USD | 7.9% |
| 2021 Q2 | 9.95 Million USD | -4.87% |
| 2021 Q1 | 10.46 Million USD | -3.46% |
| 2021 FY | 41.04 Million USD | 14.1% |
| 2021 Q3 | 10.26 Million USD | 3.14% |
| 2021 Q4 | 10.36 Million USD | 0.93% |
| 2020 Q2 | 8.73 Million USD | 13.76% |
| 2020 FY | 35.97 Million USD | -7.64% |
| 2020 Q4 | 10.83 Million USD | 24.4% |
| 2020 Q3 | 8.71 Million USD | -0.31% |
| 2020 Q1 | 7.68 Million USD | -38.01% |
| 2019 Q2 | 7.85 Million USD | -13.29% |
| 2019 FY | 38.94 Million USD | 78.59% |
| 2019 Q3 | 9.64 Million USD | 22.89% |
| 2019 Q1 | 9.05 Million USD | 46.65% |
| 2019 Q4 | 12.39 Million USD | 28.44% |
| 2018 Q2 | 12.39 Million USD | -6.93% |
| 2018 Q3 | 5.2 Million USD | -57.99% |
| 2018 FY | 21.8 Million USD | 28.22% |
| 2018 Q1 | 13.31 Million USD | 0.0% |
| 2018 Q4 | 6.17 Million USD | 18.57% |
| 2017 FY | 17 Million USD | 11.14% |
| 2016 FY | 15.3 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 49.438% |
| Addus HomeCare Corporation | 248.92 Million USD | 64.248% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | 24.786% |
| Amedisys, Inc. | 834.47 Million USD | 89.335% |
| American Oncology Network, Inc. | 83.97 Million USD | -5.978% |
| Astrana Health, Inc. | 112.59 Million USD | 20.961% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 84.848% |
| IMAC Holdings, Inc. | 5.02 Million USD | -1670.296% |
| biote Corp. | 98.82 Million USD | 9.948% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -152.788% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 73.646% |
| COMPASS Pathways plc | 136.91 Million USD | 35.002% |
| DocGo Inc. | 180.32 Million USD | 50.648% |
| The Ensign Group, Inc. | 335.39 Million USD | 73.465% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 52.936% |
| InnovAge Holding Corp. | 558.25 Million USD | 84.058% |
| Assure Holdings Corp. | 15.43 Million USD | -476.43% |
| The Joint Corp. | 109.22 Million USD | 18.52% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 81.883% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -387.855% |
| ModivCare Inc. | 586.89 Million USD | 84.836% |
| NewGenIvf Group Limited | 1.63 Million USD | -5328.037% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -558.935% |
| Option Care Health, Inc. | 666.62 Million USD | 86.65% |
| P3 Health Partners Inc. | 199.56 Million USD | 55.406% |
| P3 Health Partners Inc. | 199.56 Million USD | 55.406% |
| Surgery Partners, Inc. | 319.5 Million USD | 72.146% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -1969.892% |
| Talkspace, Inc. | 97.58 Million USD | 8.806% |
| Talkspace, Inc. | 97.58 Million USD | 8.806% |
| The Oncology Institute, Inc. | 136.59 Million USD | 34.846% |
| The Oncology Institute, Inc. | 136.59 Million USD | 34.846% |